ClinicalTrials.gg
Sign In

Status Epilepticus clinical trials

The registry lists 124 studies for Status Epilepticus across more than 10 countries. 37 are recruiting or about to start. 96 of them are mainly about Status Epilepticus (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.

Get an email when these change. Save the Status Epilepticus studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
58
Recruiting
29
Terminated
11
Status unknown
10
Not yet recruiting
8
Withdrawn
6

Phase

Phase 3
29
Phase 2
19
Phase 4
5
Phase 1
4
Early Phase 1
1

Where

United States
41
France
17
Switzerland
9
Canada
9
United Kingdom
8
Egypt
7

Who runs them

University Hospital, Basel, Switzerland (5) · Assistance Publique - Hôpitaux de Paris (5) · Sohag University (5) · Marinus Pharmaceuticals (4) · Versailles Hospital (4) · University Hospital Marburg (3) · Assiut University (3) · Supernus Pharmaceuticals, Inc. (3)

What is being tested here

Drugs under test in Status Epilepticus studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ketamine356
Levetiracetam2413
Phenobarbital113
Midazolam102
Perampanel102
Lorazepam0810
Valproic Acid025
Fosphenytoin023
Ganaxolone023
Clonazepam022

Drug classes tested here Anxiolytics 10

Coming up

7phase 3 studies under way
12studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 29 Status Epilepticus studies recruiting now, 16 (55%) set no upper age limit and 8 (28%) stop at 75 or younger. 14 (48%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (7%) take healthy volunteers.

Recruiting studies that take each age, of 29
AgeWomenMen
1010 (34%)10 (34%)
1823 (79%)23 (79%)
3021 (72%)21 (72%)
4021 (72%)21 (72%)
5021 (72%)21 (72%)
6521 (72%)21 (72%)
7521 (72%)21 (72%)
8518 (62%)18 (62%)

Across all 124 studies, recruiting or not: 35% stop at 75 or younger and 33% at 65; 51% take children; 0% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Status Epilepticus studies take

Of 22 interventional studies with no phase under Status Epilepticus, half reached primary completion within 42 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase42 mo9–65 · 22 studies——
Observational35 mo14–… · 20 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 124. Browse all 124 → or search them.